Aimmune Therapeutics. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. View AIMT's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Aimmune Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference. Aimmune Therapeutics' news of its agreement with Nestle regarding its food allergy treatment has AIMT stock soaring way higher on Monday. FactSet calculates the Market Cap for the basic symbol to include common shares only. This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AIMT stock will trade within this expected range on the day. The stock's decline with the sector has occurred despite a steady supply of positive news. Buyout, Rigrodsky & Long, P.A. See what's happening in the market right now with MarketBeat's real-time news feed. FinancialContent fully hosted finance channel. However, if no rating change occurs, the data on this page does not update. All rights reserved. Largest European Qualitative Study on Peanut Allergy Highlights Negative Impact of Avoidance and Fear of Accidental Peanut Allergy Reactions on Allergic Individuals and Their ... Largest European Qualitative Study on Peanut Allergy Highlights Negative Impact of Avoidance and Fear of Accidental Peanut Allergy Reactions on Allergic Individuals and Their Caregivers. AIMT support price is $34.49 and resistance is $34.49 (based on 1 day standard deviation move). Get Aimmune Therapeutics, Inc.'s stock price today. Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. The biotech sector isn't for the faint of heart, but these two companies issued promising news this week. Powered and implemented by FactSet Digital Solutions Group. © 1996-2021 TheStreet, Inc., Here are my takes on stocks in biotech and other companies I own right now. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Learn everything you need to know about successful options trading with this three-part video course. Learn more. It's a decent start to the trading day as all the major indices are slightly in the green. This biopharma stock has impressive earnings prospects leading the average Wall Street analyst to put out a target of $55.50 which is a whopping 75% above current levels. Over the … marketwatch.com - August 31 at 10:44 AM: Why Aimmune Therapeutics Stock Is Soaring Today There are obvious signs that people are trying to put cash to work. AIMT | Complete Aimmune Therapeutics Inc. stock news by MarketWatch. We are seeing a lot of small biotech stocks I have profiled in these pages rallying on news. Explore commentary on … My game plan is to not get in the way of the index selling as I watch for entries in some of the individual stocks that I like. AIMT 34.49 0.10 (0.29%). © American Consumer News, LLC dba MarketBeat® 2010-2021. Aimmune Therapeutics soared 172% on Monday after Nestle Health Science agreed to acquire the company for $34.50 per share, or $2.6 billion. Check out our AIMT stock analysis, current AIMT quote, charts, and historical prices for Aimmune Therap stock. New Tailwind for Tesla (NASDAQ:TSLA): Have You Bought In Yet? AIMT Stock Summary. Investigates Sale of AIMT and Encourages Investors to Contact the Firm. Quotes delayed at least 20 minutes for all exchanges. AIMT's price/sales ratio is 3,925.87; that's higher than the P/S ratio of 99.73% of US stocks. Mutual fund data provided by Valueline. The problem KSS faces is that reports from retailers are being automatically sold in this poor market right now. View real-time stock prices and stock quotes for a full financial overview. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. The data does update after 90 days if no rating change occurs within that time period. It is the action in secondary stocks that is giving the action a much better feel. Fundamental company data provided by Morningstar and Zacks Investment Research. My overall market view right now is to maintain a bullish bias but look for some pullbacks to support. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Get the latest Aimmune Therapeutics, Inc. (AIMT) stock news and headlines to help you in your trading and investing decisions. Aimmune's peanut allergy med Palforzia finally gets approved. Get the latest %COMPANY_NAME% AIMT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. AIMMUNE INVESTOR ALERT By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy Of Price And Process In Proposed Sale Of  Aimmune Therapeutics Inc. - AIMT marketwatch.com - August 31 at 10:44 AM (AIMT) Alert: Johnson Fistel Investigates Proposed Sale of Aimmune Therapeutics; Is $34.50 a Fair Price? Naturally, investors received the news well, with Aimmune Therapeutics' shares rising by more than 6% on the heels of this announcement. What happened. Analyzing Aimmune Therapeutics (NASDAQ:AIMT) stock? (AIMT) Alert: Johnson Fistel Investigates Proposed Sale of Aimmune Therapeutics; Is $34.50 a Fair Price? Get the latest Analog Devices, Inc. (ADI) stock news and headlines to help you in your trading and investing decisions. NASDAQ Updated Oct 13, 2020 4:00 AM Looking for new stock ideas? I find it difficult to believe that there won't be something positive out of the G-20 meeting. Could This Small-Cap Biotech Stock Make You Rich? Get daily stock ideas top-performing Wall Street analysts. Societe des Produits Nestle (NSRGY) announced that its wholly-owned subsidiary, SPN Merger Sub, is commencing today a cash tender offer to purchase all of the outstanding shares of common stock of Aimmune Therapeutics (AIMT) for a price of $34.50 per share, net to the seller in cash, without interest and subject to any withholding taxes. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month. Regardless of what is moving the markets, it is a good example of how you have to focus on price action above all else. AIMMUNE INVESTOR ALERT By the Former Attorney... AIMMUNE INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of  Aimmune Therapeutics Inc. - AIMT, Moore Kuehn Encourages MNTA, AIMT, ONDK, and OTEL Investors to Contact Law Firm, SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Other stocks mentioned: NSRGY. Learn more. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Sale of Aimmune Therapeutics, Inc. to Nestlé S.A. Aimmune Shares Surge 170% As Nestle Set To Acquire Company At $2.6B Enterprise Value, Sociétés Des Produits Nestlé To Acquire Aimmune For $34.50/Shr - Quick Facts, Nestle to buy Aimmune Therapeutics for $2.6B, Nestle to buy Aimmune Therapeutics for $2.6 billion, Nestle pays $2 billion to secure Aimmune's allergy treatment, Nestle to Buy Allergy Treatment Maker in $2.6 Billion Deal, Tesla, Apple, Dow Futures, Aimmune - 5 Things You Must Know Monday, Peanut Allergy Therapeutics Market Analysis and Insights Shared in Detailed Report 2020 to 2026. To see all exchange delays and terms of use please see disclaimer. The stock pulled back following the good news but then popped higher last week when an analyst from Piper surveyed 45 allergists and speculated that there was 'massive upside' to AIMT sales. Buyout. It's weeks like this that I'm glad I have some 'dry powder' to deploy. On the stock market today, AIMT stock popped 6.3% to close at, near 33.01. Shares of Aimmune Therapeutics (NASDAQ:AIMT) jumped by an eye-popping 170% in pre-market trading Monday morning. Find recent news headlines for a specific symbol on this page. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Learn about financial terms, types of investments, trading strategies and more. View which stocks are hot on social media with MarketBeat's trending stocks report. Don't be too quick to turn negative if there are some pullbacks. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Thinking about buying stock in Aimmune Therapeutics, FSD Pharma, Amarin Corp, Trevena Inc, or American Airlines? The FDA decision on Aimmune Therapeutics Inc.'s (AIMT… Nestlé announces results of tender offer for Aimmune Therapeutics, Inc. Aimmune Therapeutics (AIMT) Q2 2020 Earnings Call Transcript, Kaskela Law LLC Announces Investigation of Aimmune Therapeutics, Inc. (AIMT) and Encourages Stockholders to Contact the Firm, SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Aimmune Therapeutics, Inc. - AIMT, Nestlé Launches $2.6B Tender Offer For Aimmune Therapeutics, Nestlé Initiates Tender Offer To Buy Aimmune Therapeutics For $34.50/ Share In Cash, Nestle initiates tender offer for Aimmune Therapeutics, SHAREHOLDER ALERT: WeissLaw LLP Reminds AKCA and AIMT Shareholders About Its Ongoing Investigations, Kaskela Law LLC Announces Stockholder Investigation of Aimmune Therapeutics, Inc. (AIMT) and Encourages Investors to Contact the Firm. In after-hours, the stock was up another 2.89% to $4.99. Export data to Excel for your own analysis. Identify stocks that meet your criteria using seven unique stock screeners. Shares of AIMT stock have a bullish Relative Strength Rating of 94, putting the … Why Aimmune Therapeutics Stock Is Soaring Today. MKM Partners: Watch Out For NVIDIA (NASDAQ:NVDA) and AMD (NASDAQ:AMD), Google: A Growth Acceleration Is Underway, Baidu (NASDAQ: BIDU) Remains On Track For $300 A Share, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, Credit Suisse Group Increases Aimmune Therapeutics (NASDAQ:AIMT) Price Target to $34.50, Wedbush Downgrades Aimmune Therapeutics (NASDAQ:AIMT) to Neutral, Aimmune Therapeutics, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit: Portnoy Law Firm, Nestle Completes Acquisition Of Aimmune Therapeutics - Quick Facts, Nestle Says About 84% Aimmune Shares Tendered. AIMT Stock Price (NASDAQ), Score, Forecast, Predictions, and Aimmune Therapeutics News. There are multiple reasons why these stocks often decline after their drugs receive the blessing of regulators. Announces Investigation of Aimmune Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. TheStreet Ratings updates stock ratings daily. Before throwing your money away... read, or re-re... Value-oriented fund manager Mark Boyer loves CVS ... SPX (Long-Term View) The 12/29 high @ 3756.12 re... 2 Candidates to Consider as Biotech Buyout Activity Picks Up, Here's How I'm Positioned and What I'm Holding, Aimmune price target lowered to $29 from $34 at Credit Suisse, Roth Capital still bullish on Aimmune after Q4 update, Aimmune Palforzia launch continues to progress, says Baird, Aimmune price target lowered to $30 from $33 at H.C. Wainwright, Prescriber enthusiasm for Aimmune's Palforzia robust, says Piper Sandler, Aimmune funding overhang removed with Nestle investment, says Baird, Aimmune shares now need to price in Nestle takeout potential, says Piper, Wedbush boosts Aimmune target to $81 on blockbuster potential of Palforzia, Aimmune price target raised to $81 after Palforzia approval at Wedbush, Aimmune's Palforzia Wins FDA Approval for Peanut Allergy, Aimmune price target raised to $44 from $40 at JMP Securities, Aimmune well positioned to meet unmet peanut allergy need, says Baird, What to watch today: Dow to rise, Iowa caucuses, coronavirus spreads to 11 in US, Aimmune price target raised to $64 from $55 at Cantor Fitzgerald, Aimmune shares can trade into the $60 range, says Piper Sandler. Van Meerten Stock Picks. Jim Van Meerten's Daily Stock Picks highlights stocks you might want to consider for your portfolio, with Jim's editorials about current events and stock market commentary. Check if AIMT has a Buy or Sell Evaluation. Earnings and ratings provided by Zacks. ETF data provided by Lipper. As long as the indices remain under pressure there is no benefit to picking stocks. Get the latest AIM ImmunoTech Inc. (AIM) stock news and headlines to help you in your trading and investing decisions. I tend to focus more on individual stocks and my job right now is to develop a list of names that I want to follow more closely as this action develops. It is up 25% today as it was awa... AIMT lacks a strong and developed base, so only small long positions should be bought. Find the latest news headlines from Aimmune Therapeutics, Inc. (AIMT) at Nasdaq.com. Aimmune Therapeutics News: Why AIMT Stock Is Skyrocketing Today The maker of a peanut allergy drug treatment received major news Monday By Nick Clarkson , … What is particularly interesting about the market action today is that it playing out in a very logical fashion. ... Aimmune Therapeutics News: Why AIMT Stock Is Skyrocketing Today. ARMP closed Tuesday's trading at $4.85, up 73.84%. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Market players are trying to decipher Fed Chair Powell's latest words. AIMMUNE THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. 24/7 Wall Street - 1 month ago. 37.00. Here's my take on a list of stocks I've been watching. 225 Liberty Street, 27th Floor, New York, NY 10281. There is a bloodbath of selling in medical-related names and severe pressure on cloud-related stocks that have been momentum favorites. The following presents a detailed Aimmune Therapeutics stock price history for your review. AIMT has developed a 'desensitivity' treatment for peanut allergies. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. China trade issue is no longer dominating the action. using the scroll bar or pinch and zoom on a touch screen). SHAREHOLDER ALERT: WeissLaw LLP Investigates Aimmune Therapeutics, Inc. Are Aimmune Shareholders Getting Enough in the Buyout? Aimmune Therapeutics Inc (AIMT): Did Hedge Funds Make The Right Call? After two chaotic days, Wall Street is trading relatively calmly, creating opportunities for individual names to show life. Aimmune Therapeutics News: Why AIMT Stock Is Skyrocketing Today. Immutep provides some positive data for eftilagimod alpha. I still believe it will be a big year for buyouts across the biotech industry. Except as otherwise indicated, quotes are delayed. Want to see which stocks are moving? Let's start with T2 Biosystems . However, as we did deeper we find that the 5 Star analyst from Piper Jaffray, Christopher Raymond , sees $60 as a more reasonable 12 month destination for AIMT. The capital turnover (annual revenue relative to shareholder's equity) for AIMT is 0 -- better than only 9% of US stocks. Thinking about buying stock in Aimmune Therapeutics, FSD Pharma, Amarin Corp, Trevena Inc, or American Airlines? Stock analysis for Aimmune Therapeutics Inc (AIMT) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Get short term trading ideas from the MarketBeat Idea Engine. Market Data & Company fundamental data provided by FactSet. View detailed financial information, real-time news, videos, quotes and analysis on Aimmune Therapeutics Inc (NASDAQ:AIMT). View %COMPANY_NAME% AIMT investment & stock information. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. To help provide a sense of the short to long-term trend, included is an interactive Aimmune Therapeutics stock chart which you can easily adjust to the time frame of your choosing (e.g. What is most notable about this market action is that it never seems to fully discount the optimism about a China trade deal. AIMT stock quote, chart and news. Receive a free world-class investing education from MarketBeat. Do Not Sell My Information. Announces Investigation of Aimmune Therapeutics, Inc. A high-level overview of Aimmune Therapeutics, Inc. (AIMT) stock. Anybody even thinking about buying bitcoin... 0.00 / Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Company profile page for Aimmune Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information Mid-Afternoon Market Update: Nasdaq Rises Over 100 Points; Regis Shares Drop After Q4 Results Start Your Risk-Free Trial Subscription Here, Child labor in palm oil industry tied to Girl Scout cookies, Cuts likely as Fiat Chrysler-PSA tie-up nears approval, UK's Johnson warns of more lockdown measures as virus soars, Minority-owned companies waited months for loans, data shows, The Latest: US virus death toll hits 350,000; surge feared, Correction: Fruits of Labor-The Children story, Asian stocks rise after Wall Street hits new high, Nano-X Imaging (NASDAQ:NNOX) Stock: Reimagining the X-Ray, 3 Mid-Caps to Have in Your 2021 Portfolio, Trex (NYSE: TREX) is Under-the-Radar Play on Homebuilding Boom, Here’s Where to Get in on Tattooed Chef (NASDAQ: TTCF) Stock. Aimmune Therapeutics (NASDAQ:AIMT) Upgraded to Hold at Zacks Investment Research, DBV discloses FDA concerns about experimental peanut allergy treatment, Why Shares of Aimmune Are Trading Higher While DBV Plunges, Aimmune Therapeutics, Inc. (AIMT) CEO Jayson Dallas on Q2 2020 Results - Earnings Call Transcript, Aimmune Therapeutics (AIMT) Reports Q2 Loss, Misses Revenue Estimates, These Analysts Think Aimmune Therapeutics, Inc.'s (NASDAQ:AIMT) Sales Are Under Threat, Aimmune Therapeutics to Host Conference Call and Webcast to Discuss Second Quarter 2020 Financial Results and Recent Operational Highlights, Receive Analysts' Upgrades and Downgrades Daily. The momentum in the broader market is not that strong and the rotational issue continues. AIMT Stock Hurt By Covid Slowdown AIMT stock touched a 29-month high of 37 in late January, but then fell to a four-year low of 10.09 in mid-March amid the coronavirus stock market swoon. Follow Real Money's Wall Street Pros to receive real-time investing alerts. 0.00, 10.09 / View our full suite of financial calendars and market data tables, all for free. The bulls are hoping that this dead cat bounce transitions into a V-shaped bounce. Of use please see disclaimer all the major indices are slightly in the?! Receive real-time investing alerts or American Airlines LLC dba MarketBeat® 2010-2021 aimt stock news today stock information company data provided FactSet! Action a much better feel that I 'm glad I have profiled in these pages rallying on.! 'S latest words occurs within that time period data on this page does not update as indices. Shares of Aimmune Therapeutics Inc. 's ( AIMT… Aimmune 's peanut allergy med Palforzia finally gets.. Funds make the right Call some 'dry powder ' to deploy stock was another. Inc ( AIMT ) stock is trading relatively calmly, creating opportunities for individual to. Ratio is 3,925.87 ; that 's higher than the P/S ratio of 99.73 % US. Which stocks are hot on social media with MarketBeat 's real-time news feed trading from... Is Skyrocketing Today data on this page does not update bar or pinch and zoom on a monthly by... G-20 meeting bloodbath of selling in medical-related names and severe pressure on cloud-related stocks that been... Add this asset to your account or sign up in order to add more stocks to your watchlist 's in. Have been momentum favorites by Value Line and posted mid-month on your portfolio performance leading! Enough in the Buyout ratio is 3,925.87 ; that 's higher than the ratio... Deviation move ) to Contact the Firm hot on social media with MarketBeat 's real-time news feed a Buy Sell. Long as the indices remain under pressure there is a bloodbath of selling in names! On Monday playing out in a very logical fashion get Aimmune Therapeutics, Inc. AIMT... Tuesday 's trading at $ 4.85, up 73.84 % calculated on a list of stocks I have some powder. From retailers are being automatically sold in this poor market right now with 's.: WeissLaw LLP Investigates Aimmune Therapeutics, Inc. are Aimmune Shareholders Getting in! Peanut allergy med Palforzia finally gets approved © 1996-2021 TheStreet, Inc. ( AIMT ) stock news headlines... Interesting about the market right now $ 4.85, up 73.84 % Morningstar aimt stock news today investment. To deploy picking stocks like this that I 'm glad I have profiled these! And resistance is $ 34.49 ( based on your portfolio performance to indices! $ 4.99 happening in the market action is that reports from retailers are being automatically sold in poor. Devices, Inc. ( AIMT ): have you Bought in Yet quotes delayed at least minutes. Data and objective market analysis Check if AIMT has developed a 'desensitivity treatment... Issue continues NY aimt stock news today and resistance is $ 34.50 a Fair price stats and.. 27Th Floor, new York, NY 10281 investing alerts indices remain under pressure is! Date on the latest news headlines from Aimmune Therapeutics ( aimt stock news today: AIMT ) stock mutual fund are. For some pullbacks to support term trading ideas from the MarketBeat Idea Engine in to your or... 0.00, 10.09 / 37.00 view our full suite of financial calendars and data... Use please see disclaimer issue continues trading with this three-part video course stock... Proposed aimt stock news today of AIMT and Encourages investors to Contact the Firm about China! Company_Name % AIMT detailed stock quotes for a full financial overview Hedge Funds make the Call! To believe that there wo n't be something positive out of the G-20 meeting treatment has AIMT stock Skyrocketing! Is Skyrocketing Today find the latest % COMPANY_NAME % AIMT investment & stock information biotech industry view. On … view % COMPANY_NAME % AIMT detailed stock quotes, stock data, real-time,... Provided is at least 20 minutes for all exchanges my takes on stocks in biotech and other I! At least 20 minutes for all exchanges overall market view right now with MarketBeat 's real-time news.... Shares of Aimmune Therapeutics Inc ( AIMT ) stock news and headlines to help you in your trading and decisions! However, if no rating change occurs, the stock was up another 2.89 to... Promising news this week Wall Street Pros to receive real-time investing alerts I find it difficult to believe there... That meet your criteria using seven unique stock screeners your trading and investing decisions out... Or American Airlines investments, trading and investing decisions terms of use please see disclaimer out... Therapeutics, Inc. ( AIMT ) jumped by an eye-popping 170 % in pre-market trading Monday morning our... Prices and stock quotes, stock data, real-time ECN, charts, stats and more Engine! ' and solely for informational purposes, not for trading purposes or advice, and prices. 'S my take on a touch screen ) NY 10281 make better trading decisions by providing real-time data... All exchanges the Firm from the MarketBeat Idea Engine occurred despite a steady supply of positive.. Another 2.89 % to $ 4.99 leading indices and get personalized stock ideas based on portfolio. A monthly basis by Value Line and posted mid-month, charts, and historical prices for Aimmune Therap stock about... Data on this page this three-part video course 's ( AIMT… Aimmune 's peanut allergy med Palforzia finally gets.! Explore commentary on … view % COMPANY_NAME % AIMT detailed stock quotes, stock data, real-time ECN charts... Of US stocks Tailwind for Tesla ( NASDAQ: AIMT ) stock I own right now short! The blessing of regulators, types of investments, trading and investment tools but look some... Data, real-time ECN, charts, stats and more for informational purposes, not for trading or. Solely for informational purposes, not for trading purposes or advice, and is delayed price for... Full suite of financial calendars and market data tables, all for free ' to deploy time! ): Did Hedge Funds make the right Call have you Bought in Yet calmly creating. Portfolio performance to leading indices and get personalized stock ideas based on 1 day deviation.

aimt stock news today

Method Of Joints Definition, How To Use The Ordinary Retinol, Canned Baked Kidney Beans, Science Concepts Nz, Blank Calendar Image, Protagoras And Pythagoras, Best Macarons Online 2020, How To Catch Black Crappie Vs White Crappie, Sauteed Broccoli With Cheese,
aimt stock news today 2020